Fundraising Fox

Synthesize

Founded 2023 · 23 employees on LinkedIn · 4 known investors

Synthesize develops generative AI models that simulate human tissue responses to drugs and diseases for clinical trial design. The company helps biotech and pharmaceutical development teams de-risk trials, identify biomarkers, and extend early-phase data by generating synthetic patient cohorts.

Founders & leadership

Synthesize was founded in 2023 by Robert Bradley, PhD and Jeff Leek, PhD.

RBRobert Bradley, PhD
Robert Bradley, PhDinFounder
JLJeff Leek, PhD
Jeff Leek, PhDinFounder
AWAlice Walsh, PhD
Alice Walsh, PhDinFounder
GKGregory Koytiger, PhD
Gregory Koytiger, PhDinFounder
ABAriel Brumbaugh, PhD
Ariel Brumbaugh, PhDinFounder
SSStein Setvik
Stein SetvikinFounder
LRLiza Ray, MBA
Liza Ray, MBAinFounder

Investors · 4

Competitors · 3

by search overlap

Companies competing with Synthesize for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Frequently asked questions

What does Synthesize do?
Synthesize develops generative AI models that simulate human tissue responses to drugs and diseases for clinical trial design. The company helps biotech and pharmaceutical development teams de-risk trials, identify biomarkers, and extend early-phase data by generating synthetic patient cohorts.
Who founded Synthesize?
Synthesize was founded by Robert Bradley, PhD, Jeff Leek, PhD in 2023.
Who are Synthesize's investors?
Synthesize's investors include Madrona Venture Group, AI2 Incubator, Inner Loop Capital, Sahsen Ventures.